Carbiotix to present at Life Science-dagen in Göteborg
Carbiotix (publ) ("Carbiotix") announces today that Kristofer Cook, CEO of Carbiotix, will be giving a live-stream presentation at Life Science-Dagen in Göteborg on the 4th of March at 13:45 (CET). The public can follow the presentation at www.lifesciencedagen.se. In light of recent announcements, Kristofer will be providing an update of the company’s products and services, with a special focus on the link between gut health and immune system integrity and solutions offered by Carbiotix.
Life Science-dagen will take place at the Wallenberg Conference Centre by the Sahlgrenska Univerity Hospital in Göteborg, Sweden between 8:00-18:00 (CET) on the 4th of March 2020, and will be livestreamed to the public. Carbiotix presentation will be one of fifteen presentations during the day by listed and unlisted Nordic Life Science companies. Expected visitors will include investors, medical professionals and other parties interested in the Life Science industry, with up to 350 attendees expected.
Kristofer Cook, CEO for Carbiotix, comments
“Presenting at Life Science-dagen is a great opportunity to provide an update of our product and service offering as well as development pipeline to interested parties in Sweden and abroad, especially in light of recent announcements related to our plans to accelerate the market introduction of our prebiotic ingredient and launch of a medical food in 2021. I will also be drawing special attention to the link between gut health and immune system integrity, and what Carbiotix can offer in terms of solutions to better understand gut health and improve it.”
For further information:
Carbiotix AB
Kristofer Cook, CEO
Tel: 0708-796580
E-mail: kristofer.cook@carbiotix.com
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.